News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories News Where AI Agents Fit in Healthcare Operations News Mercury Systems Acquires SolderMask To Support Higher Rate Production News Nominal Selected by Forterra to Power Data Infrastructure for Defense Autonomy Programs News NRSInsights’ February 2026 Retail Same-Store Sales Report News AssureSoft Scales Its Nearshore Model With New Development Hubs In LATAM News NEW TOUGHBOOK 56 REIMAGINES RUGGED MOBILITY & USABILITY FOR FIELD WORKERS
